跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REWISCA HARD CAPSULES 25MG - HSA Drug Approval Details
Approvals
/
HSA
/
REWISCA HARD CAPSULES 25MG
Approved
THERAPEUTIC
REWISCA HARD CAPSULES 25MG
KRKA, D.D., NOVO MESTO (SLOVENIA)
🇸🇬 Health Sciences Authority
Approval Date
Apr 2, 2019
Approval ID
f35837310844ad1e
Company
KRKA, D.D., NOVO MESTO (SLOVENIA)
Type
Therapeutic
Approval Details
Approval Id
f35837310844ad1e
Drug Name
REWISCA HARD CAPSULES 25MG
Product Name
REWISCA HARD CAPSULES 25MG
Approval Number
SIN15657P
Approval Date
2019-04-02
Registrant
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Licence Holder
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
N03AX16
Atc Item Name
xn 03 ax 16
Pharma Manufacturer Name
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Company Detail Path
/organization/singapore-pharmaceutical-private-limited
Active Ingredients
Pregabalin
25.00mg
PREGABALIN
25 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 2, 2019
Approval ID
f35837310844ad1e
Type
Therapeutic
Back to HSA Approvals